BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 21563983)

  • 21. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
    Hope MJ; Mui B; Ansell S; Ahkong QF
    Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted polymers for gene delivery.
    Hughes JA; Rao GA
    Expert Opin Drug Deliv; 2005 Jan; 2(1):145-57. PubMed ID: 16296741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymeric drug delivery systems for localized cancer chemotherapy.
    De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
    Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting strategies in cancer gene therapy.
    Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in polymeric micelles for drug delivery and tumor targeting.
    Kedar U; Phutane P; Shidhaye S; Kadam V
    Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid-based therapeutics for glioblastoma.
    Shir A; Levitzki A; Wagner E; Klein S; Ogris M
    Anticancer Agents Med Chem; 2011 Oct; 11(8):693-9. PubMed ID: 21707501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
    Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
    Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, preparation and application of nucleic acid delivery carriers.
    Yang J; Liu H; Zhang X
    Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptide.
    Wong SC; Wakefield D; Klein J; Monahan SD; Rozema DB; Lewis DL; Higgs L; Ludtke J; Sokoloff AV; Wolff JA
    Mol Pharm; 2006; 3(4):386-97. PubMed ID: 16889432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene therapy: nucleic acids as drugs. Action mechanisms and delivery into the cell].
    Cavagnari BM
    Arch Argent Pediatr; 2011 Jun; 109(3):237-44. PubMed ID: 21660389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleic acid carriers based on precise polymer conjugates.
    Troiber C; Wagner E
    Bioconjug Chem; 2011 Sep; 22(9):1737-52. PubMed ID: 21749135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
    Guo J; Bourre L; Soden DM; O'Sullivan GC; O'Driscoll C
    Biotechnol Adv; 2011; 29(4):402-17. PubMed ID: 21435387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid and polymeric carrier-mediated nucleic acid delivery.
    Zhu L; Mahato RI
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1209-26. PubMed ID: 20836625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary delivery of nucleic acids.
    Birchall J
    Expert Opin Drug Deliv; 2007 Nov; 4(6):575-8. PubMed ID: 17970661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.